A comparison of immune reconstitution and graft-versus-host disease following myeloablative conditioning versus reduced toxicity conditioning and umbilical cord blood transplantation in paediatric recipients. [electronic resource]
Producer: 20111128Description: 218-34 p. digitalISSN:- 1365-2141
- Alemtuzumab
- Antibiotic Prophylaxis
- Antibodies, Monoclonal, Humanized -- administration & dosage
- Antibodies, Neoplasm -- administration & dosage
- Antilymphocyte Serum
- Busulfan -- administration & dosage
- Child
- Child, Preschool
- Cord Blood Stem Cell Transplantation -- methods
- Cyclophosphamide -- administration & dosage
- Female
- Genetic Diseases, Inborn -- surgery
- Graft Survival
- Graft vs Host Disease -- epidemiology
- Granulocyte Colony-Stimulating Factor -- therapeutic use
- Granulocyte-Macrophage Colony-Stimulating Factor -- therapeutic use
- Humans
- Leukocyte Count
- Male
- Melphalan -- administration & dosage
- Myeloablative Agonists -- administration & dosage
- Neoplasms -- surgery
- Neutrophils
- Recombinant Proteins -- therapeutic use
- Retrospective Studies
- T-Lymphocytes
- Transplantation Conditioning -- methods
- Transplantation, Homologous
- Vidarabine -- administration & dosage
- Whole-Body Irradiation
No physical items for this record
Publication Type: Comparative Study; Evaluation Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.